We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 4,667

No antitrust immunity for state boards run by market participants

  • Hogan Lovells
  • -
  • USA
  • -
  • March 26 2015

On February 25 the Supreme Court ruled that state professional boards controlled by private entities must be actively supervised by state governments

Antitrust “state action” exemption: North Carolina State Board of Dental Examiners v. Federal Trade Commission

  • Pillsbury Winthrop Shaw Pittman LLP
  • -
  • USA
  • -
  • March 26 2015

On February 25, 2015, the U.S. Supreme Court issued its decision in North Carolina State Board of Dental Examiners v. Federal Trade Commission

Antitrust enforcement in the medical devices sector

  • Sidley Austin LLP
  • -
  • USA
  • -
  • March 25 2015

Enforcement agencies and courts in the United States have long dealt with high-profile antitrust cases in the pharmaceutical sector. However, until

U.S. FTC revises merger challenge rules: automatic stay of administrative litigation when agency loses preliminary injunction in court

  • Jones Day
  • -
  • USA
  • -
  • March 25 2015

One important procedural difference between merger challenges by the U.S. Department of Justice and the Federal Trade Commission is that FTC may

Recent antitrust class actions related to contact lenses

  • Arnall Golden Gregory LLP
  • -
  • USA
  • -
  • March 24 2015

On March 3, 2015, the four largest contact lens manufacturers and a contact lens wholesaler were sued based on allegations that they violated federal

Biosimilars in the US: still at the starting line?

  • DLA Piper LLP
  • -
  • USA
  • -
  • March 24 2015

Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) in 2009 to create a framework for the introduction of biosimilar and

Supreme Court asked to clarify the reach of U.S. antitrust laws to foreign conduct

  • McDermott Will & Emery
  • -
  • USA
  • -
  • March 24 2015

On March 16, 2015, AU Optronics Corporation America Inc. (AU Optronics) and Motorola Mobility LLC separately asked the U.S. Supreme Court to clarify

Plausibly alleging non-monetary settlements as reverse payments after Actavis

  • Patterson Belknap Webb & Tyler LLP
  • -
  • USA
  • -
  • March 24 2015

In In re Lipitor Antitrust Litigation, No. 12 Civ. 2389 (D.N.J.), U.S. District Judge Peter G. Sheridan has confirmed his prior ruling that under the

2015 antitrust annual report

  • Shearman & Sterling LLP
  • -
  • USA
  • -
  • March 23 2015

The current EU merger control regime only empowers the EC to intervene and block or modify transactions if there is a “substantial impediment to

Joint FTC and DOJ workshop on healthcare competition highlights the importance of antitrust

  • Manatt Phelps & Phillips LLP
  • -
  • USA
  • -
  • March 23 2015

On February 24 and 25 in Washington, DC, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) held a joint Antitrust Division